[HTML][HTML] 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum
K AlexanderErik, N PearceElizabeth, A BrentGregory… - Thyroid, 2017 - liebertpub.com
Background: Thyroid disease in pregnancy is a common clinical problem. Since the
guidelines for the management of these disorders by the American Thyroid Association …
guidelines for the management of these disorders by the American Thyroid Association …
[HTML][HTML] Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?
S Palomba, S Santagni, GB La Sala - Journal of Ovarian Research, 2015 - Springer
Luteal phase deficiency (LPD) is described as a condition of insufficient progesterone
exposure to maintain a regular secretory endometrium and allow for normal embryo …
exposure to maintain a regular secretory endometrium and allow for normal embryo …
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial
A Nyboe Andersen, SM Nelson, BCJM Fauser… - Fertility and …, 2017 - iris.unimore.it
Objective To compare the efficacy and safety of follitropin delta, a new human recombinant
FSH with individualized dosing based on serum antimüllerian hormone (AMH) and body …
FSH with individualized dosing based on serum antimüllerian hormone (AMH) and body …
[HTML][HTML] Factors associated with ovarian hyperstimulation syndrome (OHSS) severity in women with polycystic ovary syndrome undergoing IVF/ICSI
B Sun, Y Ma, L Li, L Hu, F Wang, Y Zhang… - Frontiers in …, 2021 - frontiersin.org
Introduction Age, polycystic ovary syndrome (PCOS), low body mass index (BMI), high antral
follicle count (AFC), increased anti-Muller hormone (AMH) levels, and elevated serum …
follicle count (AFC), increased anti-Muller hormone (AMH) levels, and elevated serum …
[HTML][HTML] Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority …
AN Andersen, SM Nelson, BCJM Fauser… - Fertility and …, 2017 - Elsevier
Objective To compare the efficacy and safety of follitropin delta, a new human recombinant
FSH with individualized dosing based on serum antimüllerian hormone (AMH) and body …
FSH with individualized dosing based on serum antimüllerian hormone (AMH) and body …
[HTML][HTML] Kisspeptin Modulation of Reproductive Function
A Szeliga, B Meczekalski - Endocrines, 2022 - mdpi.com
Kisspeptin is a peptide expressed mainly in the infundibular nucleus of the hypothalamus.
Kisspeptin plays a crucial role in the regulation of reproductive functions. It is regarded as …
Kisspeptin plays a crucial role in the regulation of reproductive functions. It is regarded as …
Development of children born from IVM versus IVF: 2-year follow-up of a randomized controlled trial
STUDY QUESTION Is there any difference in developmental outcomes in children born after
capacitation IVM (CAPA IVM) compared with conventional IVF? SUMMARY ANSWER …
capacitation IVM (CAPA IVM) compared with conventional IVF? SUMMARY ANSWER …
The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian …
L Sekhon, K Shaia, A Santistevan, KH Cohn… - Journal of Assisted …, 2017 - Springer
Objective Controlled ovarian hyperstimulation (COH) promotes multifollicular growth,
increasing the chance of obtaining euploid embryos that will successfully implant. Whether …
increasing the chance of obtaining euploid embryos that will successfully implant. Whether …
The direct and indirect effects of kisspeptin-54 on granulosa lutein cell function
STUDY QUESTION What are the in vivo and in vitro actions of kisspeptin-54 on the
expression of genes involved in ovarian reproductive function, steroidogenesis and ovarian …
expression of genes involved in ovarian reproductive function, steroidogenesis and ovarian …
[HTML][HTML] The" Begin Exploring Fertility Options, Risks and Expectations"(BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal …
B Speller, K Metcalfe, ED Kennedy, M Facey… - BMC medical informatics …, 2019 - Springer
Background Premenopausal breast cancer patients are at risk of treatment-related infertility.
Many patients do not receive sufficient fertility information before treatment. As such, our …
Many patients do not receive sufficient fertility information before treatment. As such, our …